Contribution of chromosome versus gonadal sex to bone mass and strength
染色体与性腺性别对骨量和强度的贡献
基本信息
- 批准号:10711910
- 负责人:
- 金额:$ 39.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-15 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AbbreviationsAddressAffectAge MonthsAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAnimalsArginineBone DensityBrainCell CountCell physiologyChromosomesDNA Sequence AlterationDementiaDiagnosisDissociationElderlyExhibitsExploratory/Developmental Grant for Diagnostic Cancer ImagingFemaleFemurFour Core GenotypesFractureFrequenciesFundingGenderGeneral PopulationGenerationsGenotypeGoalsGonadal Steroid HormonesGonadal structureHealthHigh PrevalenceHip region structureHistidineIndividualKnowledgeLinkLongevityMeasuresMental disordersMicrogliaModelingMolecularMusMutationMyeloid CellsNeurologicObesityOsteoclastsOsteoporosisOvaryPatternPhenotypePhysiologicalPredispositionReportingRiskRisk FactorsRoleSex ChromosomesSex DifferencesSkeletonStructureTREM2 geneTestingTestisTransgenesTransgenic OrganismsVariantWild Type MouseWomanX ChromosomeY Chromosomebiomechanical testbonebone cellbone fragilitybone healthbone lossbone massbone strengthcirculating biomarkersdementia riskgenetic manipulationgenotypic sexhigh riskimprovedmalemenmortalitynervous system disorderpreventsexsexual dimorphismskeletalsry Genesstem
项目摘要
SUMMARY
Alzheimer's disease (AD) is a growing health concern and is the most common type of dementia worldwide,
affecting women with higher frequency. Evidence indicates that mental illness and neurological and nervous
system disorders can increase the risk of developing osteoporosis leading to high prevalence of bone frac-
tures. Fractures, in particular of the hip, have been associated with increased mortality, especially in the elder-
ly. Conversely, osteoporosis is associated with higher risk of dementia diagnosis. Yet, a direct link between
dementia and osteoporosis, frequently occurring with aging, has never been conclusively demonstrated. Inter-
estingly, some genetic mutations are risk factors for both AD and osteoporosis. For example, mutations of the
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2), a molecule expressed in microglia in brain and in
osteoclasts in bone correlate with AD and dementia, and with bone fragility. Recent studies showed that mice
expressing the TREM2 R47H variant (TREM2R47H/+ mice) exhibit loss of TREM2 function and neuritic dystro-
phy. However, the mechanisms responsible for the TREM2 mutation effects on bone mass and strength are
completely unclear. We have shown that females TREM2R47H/+ mice exhibit low bone mass accrual compared
to wild type littermates, whereas no changes were observed in males. In addition, female, but not male,
TREM2R47H/+ mice exhibit low total and femur BMD at 5.5, but not at 4 months of age, compared to wild type
littermates. Yet, the mechanism by which aging has a stronger effect in female TREM2R47H/+ compared wild
type mice is not known. Our long-term goal is to understand the basis for bone sexual dimorphism. The ob-
jective of this supplement is to extend the original studies funded by the R21 award to a model of increased
risk of developing AD, with the aim to start uncovering the mechanisms for the increase susceptibility to devel-
oping AD in females. We propose to test the hypothesis that the differential skeletal consequences of ex-
pression of the TREM2 R47H variant result from a combination of gonadal and chromosome sex-
dependent mechanisms. To address this hypothesis, we aim to determine the contribution of gonadal
versus chromosome sex to bone mass and strength in 5.5-month-old wild type and TREM2R47H/+ mice.
Two Sub Aims are proposed. In Sub Aim a, we will examine the skeletal consequences of the TREM2 variant
in male and female mice and the role of chromosomal and gonadal sex at the structural, cellular, and molecu-
lar levels in wild type and TREM2R47H/+ XXM, XYM, XXF and XYF mice. In Sub Aim b, we will identify the cellular
mechanism that underly the sexual dimorphism in wild type and TREM2R47H/+ mice, by determining whether
osteoclasts from TREM2R47H/+ XXM, XYM, XXF and XYF mice are intrinsically different or respond to sex steroids
differently, and whether the pattern of osteoclastokines differs in a sex-dependent manner. These studies will
advance our knowledge of the mechanisms controlling bone cell function in a sex-dependent manner in the
context of increased risk to develop AD.
总结
阿尔茨海默病(AD)是一个日益严重的健康问题,是世界上最常见的痴呆症类型,
影响女性的频率更高。有证据表明,精神疾病、神经系统疾病和
系统紊乱会增加患骨质疏松症的风险,导致骨折的高发率,
图。骨折,特别是髋部骨折,与死亡率增加有关,尤其是在老年人中-
ly.相反,骨质疏松症与痴呆症诊断的高风险相关。然而,
老年痴呆症和骨质疏松症经常伴随着衰老而发生,但从未得到最终证实。间-
值得注意的是,一些基因突变是AD和骨质疏松症的危险因素。例如,
髓样细胞表达触发受体2(TREM 2),一种在脑中小胶质细胞中表达的分子,
骨中的破骨细胞与AD和痴呆以及骨脆性相关。最近的研究表明,
表达TREM 2 R47 H变体的小鼠(TREM 2 R47 H/+小鼠)表现出TREM 2功能丧失和神经炎性发育不良。
物理学然而,TREM 2突变对骨量和强度影响的机制是
完全不清楚我们已经表明,雌性TREM 2 R47 H/+小鼠表现出较低的骨量增加,
与野生型同窝仔相比,而在雄性中未观察到变化。此外,女性,而不是男性,
与野生型相比,TREM 2 R47 H/+小鼠在5.5月龄时表现出低的总BMD和股骨BMD,但在4月龄时则没有
同窝出生的然而,衰老对雌性TREM 2 R47 H/+的影响比野生型更强的机制是,
小鼠的类型未知。我们的长期目标是了解骨骼性别二型性的基础。这是...
本补充的目的是将R21奖资助的原始研究扩展到增加的模型,
发展AD的风险,目的是开始揭示发展AD的易感性增加的机制,
女性AD我们建议测试的假设,即差异骨骼的后果,前-
TREM 2 R47 H变体的表达是性腺和染色体性别的组合导致的。
依赖机制。为了解决这一假设,我们的目标是确定性腺的贡献,
与染色体性别相比,5.5月龄野生型和TREM 2 R47 H/+小鼠的骨量和强度。
提出了两个分目标。在子目标a中,我们将研究TREM 2变体的骨骼后果,
以及染色体和性腺性别在结构、细胞和分子水平上的作用。
在野生型和TREM 2 R47 H/+ XXM、XYM、XXF和XYF小鼠中具有更高水平。在子目标B中,我们将识别
野生型和TREM 2 R47 H/+小鼠中两性异形的机制,通过确定是否
来自TREM 2 R47 H/+ XXM、XYM、XXF和XYF小鼠的破骨细胞本质上不同或对性类固醇有反应
不同,以及破骨细胞因子的模式是否以性别依赖的方式不同。这些研究将
推进我们的知识机制控制骨细胞功能的性别依赖性的方式,
在AD发生风险增加的背景下。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lilian Irene Plotkin其他文献
Lilian Irene Plotkin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lilian Irene Plotkin', 18)}}的其他基金
Contribution of chromosome versus gonadal sex to bone mass and strength
染色体与性腺性别对骨量和强度的贡献
- 批准号:
10508931 - 财政年份:2022
- 资助金额:
$ 39.63万 - 项目类别:
Contribution of chromosome versus gonadal sex to bone mass and strength
染色体与性腺性别对骨量和强度的影响
- 批准号:
10666647 - 财政年份:2022
- 资助金额:
$ 39.63万 - 项目类别:
Skeletal complications to a TREM2 variant associated with Alzheimer's Disease
与阿尔茨海默病相关的 TREM2 变异的骨骼并发症
- 批准号:
10408018 - 财政年份:2021
- 资助金额:
$ 39.63万 - 项目类别:
Skeletal complications to a TREM2 variant associated with Alzheimer's Disease
与阿尔茨海默病相关的 TREM2 变异的骨骼并发症
- 批准号:
10259555 - 财政年份:2021
- 资助金额:
$ 39.63万 - 项目类别:
Skeletal complications to a TREM2 variant associated with Alzheimer's Disease
与阿尔茨海默病相关的 TREM2 变异的骨骼并发症
- 批准号:
10618952 - 财政年份:2021
- 资助金额:
$ 39.63万 - 项目类别:
Osteocyte Apoptosis and Regulation of Bone Resorption with Aging
骨细胞凋亡和骨吸收随衰老的调节
- 批准号:
9212771 - 财政年份:2015
- 资助金额:
$ 39.63万 - 项目类别:
Osteocyte apoptosis and regulation of bone resorption with aging
衰老过程中骨细胞凋亡和骨吸收的调节
- 批准号:
9308117 - 财政年份:2015
- 资助金额:
$ 39.63万 - 项目类别:
Connexin 43 Hemichannels and Signaling In Bone
Connexin 43 半通道和骨信号传导
- 批准号:
8049744 - 财政年份:2008
- 资助金额:
$ 39.63万 - 项目类别:
Connexin 43 Hemichannels and Signaling In Bone
Connexin 43 半通道和骨信号传导
- 批准号:
8241176 - 财政年份:2008
- 资助金额:
$ 39.63万 - 项目类别:
Connexin 43 Hemichannels and Signaling In Bone
Connexin 43 半通道和骨信号传导
- 批准号:
7658224 - 财政年份:2008
- 资助金额:
$ 39.63万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 39.63万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 39.63万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 39.63万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 39.63万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 39.63万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 39.63万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 39.63万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 39.63万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 39.63万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 39.63万 - 项目类别:
Research Grant














{{item.name}}会员




